全球 3D 生物列印市場按技術、組件、應用和地區分類

3D Bioprinting Market, By Technology, By Component, By Application, By Geography

出版日期: 2025年02月20日 | 出版商:

Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2025 年全球 3D 生物列印市場規模預估為 29.5 億美元，預計到 2032 年將達到 85.3 億美元，2025 年至 2032 年的複合年成長率為 16.4%。

報告範圍		報告詳細資訊
基準年	2024	2025 年市場規模	29.5億美元
效能資料	2020-2024	預測期	2025-2032
預測期：2025-2032年複合年成長率：	16.40％	2032 年價值預測	85.3億美元

圖。

報告摘要：

3D生物列印是一種新興的創新技術，利用3D列印機列印人體組織、器官和生物化學物質，用於醫學研究和臨床應用。它的工作原理是將活細胞、支架和生長因子分層，以支持活組織形成。這種開創性的方法具有巨大潛力，可以透過解決可移植器官短缺的問題來徹底改變醫療保健。基於電腦輔助設計的生物材料、活細胞和支持因素的精確空間沉積使得能夠創建複雜的 3D 組織和器官結構。透過重建組織和器官的原生微環境，3D 生物列印可以加速再生醫學領域的發展，並最終滿足器官移植的需求。

市場動態：

全球 3D 生物列印市場受到再生醫學研究資金籌措和舉措不斷增加的推動。器官移植需求的不斷成長以及器官捐贈者的短缺正在推動對生物列印技術提供的替代解決方案的投資。有利的監管準則和生物列印組織的商業化正在創造有利可圖的機會。然而，列印複雜生物結構的高運作成本和技術挑戰是一個限制。此外，缺乏專業技能和臨床試驗也對廣泛採用構成挑戰。儘管如此，各公司正在共同努力改進生物材料、細胞相容性和 3D 生物列印機的解析度。藥物動力學測試、個人化藥物篩檢和罕見疾病建模等新應用領域的出現可能會在預測期內推動市場成長。

本研究的主要特點

本研究報告對全球 3D 生物列印市場進行了詳細分析，並提供了預測期（2025-2032）的市場規模和年複合成長率（CAGR%），假設 2024 年為基準年。
它還強調了各個領域的潛在收益成長機會，並說明了該市場的引人注目的投資提案矩陣。
它還提供了關於市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的主要考察。
全球 3D 生物列印市場的主要企業是根據公司亮點、產品系列、關鍵亮點、財務表現和策略等參數進行的分析。
本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球 3D 生物列印市場報告涉及該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
相關人員將透過用於分析全球 3D 生物列印市場的各種策略矩陣來做出決策。

公司簡介
- 3D Bioprinting Solutions
- Advanced Solutions Life Sciences, LLC
- Allevi Inc.
- Aspect Biosystems Ltd.
- Bico group ab
- Bio3D Technologies Pte. Ltd.
- Cellink Global
- Collplant Biotechnologies Ltd.
- Cyfuse Biomedical KK
- Electro Optical Systems
- Envisiontec GmbH
- Foldink Life Science Technologies
- Formlabs, Inc.
- GE Healthcare
- Inventia Life Science PTY LTD
- Nano 3D Biosciences, Inc.
- Optomec Inc.
- Organovo Holdings, Inc.
- Pandorum Technologies pvt. ltd.
- Precise Bio
- Regemat 3D SL
- Regenovo Biotechnology Co. Ltd.
- Renishaw PLC.
- Revotek Co., Ltd.
- Rokit Healthcare, Inc.
- Stratasys Ltd.
- Vivax Bio, LLC

第 10 章命運之輪

命運之輪
分析師觀點
Coherent Opportunity Map（COM）

第 11 章章節：

調查方法
關於出版商

簡介目錄

Product Code: CMI5166

Global 3d Bioprinting Market is estimated to be valued at USD 2.95 Bn in 2025 and is expected to reach USD 8.53 Bn by 2032, growing at a compound annual growth rate (CAGR) of 16.4% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 2.95 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	16.40%	2032 Value Projection:	USD 8.53 Bn

Figure. 3d Bioprinting Market Share (%), By Region 2025

Report Description:

3D bioprinting is an emerging and innovative technology that utilizes 3D printers to print human tissues, organs, and biochemicals for medical research and clinical applications. It works by layering live cells, scaffolds, and growth factors capable of supporting the formation of biological tissues. This pioneering approach holds enormous potential in revolutionizing healthcare by addressing the shortage of transplantable organs. It allows the fabrication of complex 3D tissues and organ structures through precise spatial deposition of biomaterials, living cells, and supporting factors based on computer-assisted design. By replicating the native microenvironment of tissues and organs, 3D bioprinting can accelerate the field of regenerative medicine and ultimately address the demand for organ transplants.

Market Dynamics:

The global 3D bioprinting market is driven by rising funding and initiatives for research in regenerative medicines. The growing demand for organ transplants and lack of donors has boosted investments in alternative solutions offered by bioprinting technologies. Favorable regulatory guidelines and commercialization of bioprinted tissues are creating lucrative opportunities. However, high operational costs and technical challenges in printing complex living structures pose constraints. Lack of skilled expertise and clinical trials also challenge widespread adoption. Nonetheless, companies are collaborating to improve biomaterials, cell compatibility, and resolution of 3D bioprinters. The emergence of newer application areas such as pharmacokinetic testing, personalized drug screening, and rare disease modeling can boost the market growth during the forecast period.

Key Features of the Study:

This report provides an in-depth analysis of the global 3D bioprinting market, and provides market size (US$ Billion) and compound annual growth rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global 3D bioprinting market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include 3D Bioprinting Solutions, Advanced Solutions Life Sciences, LLC, Allevi Inc., Aspect Biosystems Ltd., Bico group ab, Bio3D Technologies Pte. Ltd., Cellink Global, Collplant Biotechnologies Ltd., Cyfuse Biomedical K.K., Electro Optical Systems, Envisiontec GmbH, Foldink Life Science Technologies, Formlabs, Inc., GE Healthcare, Inventia Life Science PTY LTD, Nano 3D Biosciences, Inc., Optomec Inc., Organovo Holdings, Inc., Pandorum Technologies pvt. ltd., Precise Bio, Regemat 3D S.L., Regenovo Biotechnology Co. Ltd., Renishaw plc., Revotek co., ltd., Rokit Healthcare, inc., Stratasys Ltd.Vivax Bio, LLC, and Vivax Bio, LLC
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global 3D bioprinting market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global 3D bioprinting market

Market Segmentation

By Technology
- Syringe/extrusion Bioprinting
- Inkjet Bioprinting
- Magnetic Levitation Bioprinting
- Laser-assisted Bioprinting
- Others
By Component
- 3D Bioprinters
- Biomaterials
- Scaffolds
By Application
- Drug Testing and Development
- Regenerative Medicine
- Food Testing
- Research
- Others
By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East & Africa
- GCC Countries
- South Africa
- Israel
- Rest of Middle East & Africa
Key Players Insights
- 3D Bioprinting Solutions
- Advanced Solutions Life Sciences, LLC
- Allevi Inc.
- Aspect Biosystems Ltd.
- Bico group ab
- Bio3D Technologies Pte. Ltd.
- Cellink Global
- Collplant Biotechnologies Ltd.
- Cyfuse Biomedical K.K.
- Electro Optical Systems
- Envisiontec GmbH
- Foldink Life Science Technologies
- Formlabs, Inc.
- GE Healthcare
- Inventia Life Science PTY LTD
- Nano 3D Biosciences, Inc.
- Optomec Inc.
- Organovo Holdings, Inc.
- Pandorum Technologies pvt. ltd.
- Precise Bio
- Regemat 3D S.L.
- Regenovo Biotechnology Co. Ltd.
- Renishaw plc.
- Revotek co., ltd.
- Rokit Healthcare, inc.
- Stratasys Ltd.Vivax Bio, LLC
- Vivax Bio, LLC

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Syringe/ extrusion bioprinting
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Inkjet Bioprinting
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Magnetic Levitation Bioprinting
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Laser Assisted Bioprintings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Other Technologies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global 3D Bioprinting Market, By Component, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
3D Bioprinters
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Biomaterials
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Scaffolds
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global 3D Bioprinting Market, By Application, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Drug Testing and Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Regenerative Medicine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Food Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Research
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Other Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global 3D Bioprinting Market, By Region, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Country Trends
North America
- Regional Trends
- Market Size and Forecast, By Technology, 2020-2032 (USD Billion)
- Market Size and Forecast, By Components, 2020-2032 (USD Billion)
- Market Size and Forecast, By Application, 2020-2032 (USD Billion)
- Market Share Analysis, By Country, 2025 and 2032 (%)
  - U.S.
  - Canada
Europe
- Regional Trends
- Market Size and Forecast, By Technology, 2020-2032 (USD Billion)
- Market Size and Forecast, By Components, 2020-2032 (USD Billion)
- Market Size and Forecast, By Application, 2020-2032 (USD Billion)
- Market Share Analysis, By Country, 2025 and 2032 (%)
  - U.K.
  - Germany
  - France
  - Russia
  - Rest of Europe
Asia Pacific
- Regional Trends
- Market Size and Forecast, By Technology, 2020-2032 (USD Billion)
- Market Size and Forecast, By Components, 2020-2032 (USD Billion)
- Market Size and Forecast, By Application, 2020-2032 (USD Billion)
- Market Share Analysis, By Country, 2025 and 2032 (%)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Latin America
- Regional Trends
- Market Size and Forecast, By Technology, 2020-2032 (USD Billion)
- Market Size and Forecast, By Components, 2020-2032 (USD Billion)
- Market Size and Forecast, By Application, 2020-2032 (USD Billion)
- Market Share Analysis, By Country, 2025 and 2032 (%)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Middle East & Africa
- Market Size and Forecast, By Technology, 2020-2032 (USD Billion)
- Market Size and Forecast, By Components, 2020-2032 (USD Billion)
- Market Size and Forecast, By Application, 2020-2032 (USD Billion)
- Market Share Analysis, By Country/region, 2025 and 2032 (%)
  - South Africa
  - GCC Countries
  - Rest of the Middle East & Africa

9. Competitive Landscape

Company Profiles
- 3D Bioprinting Solutions*
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Key Strategies
  - Recent Developments/Updates
- Advanced Solutions Life Sciences, LLC
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Key Strategies
  - Recent Developments/Updates
- Allevi Inc.
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Key Strategies
  - Recent Developments/Updates
- Aspect Biosystems Ltd.
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Key Strategies
  - Recent Developments/Updates
- Bico group ab
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Key Strategies
  - Recent Developments/Updates
- Bio3D Technologies Pte. Ltd.
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Key Strategies
  - Recent Developments/Updates
- Cellink Global
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Key Strategies
  - Recent Developments/Updates
- Collplant Biotechnologies Ltd.
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Key Strategies
  - Recent Developments/Updates
- Cyfuse Biomedical K.K.
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Key Strategies
  - Recent Developments/Updates
- Electro Optical Systems
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Key Strategies
  - Recent Developments/Updates
- Envisiontec GmbH
- Foldink Life Science Technologies
- Formlabs, Inc.
- GE Healthcare
- Inventia Life Science PTY LTD
- Nano 3D Biosciences, Inc.
- Optomec Inc.
- Organovo Holdings, Inc.
- Pandorum Technologies pvt. ltd.
- Precise Bio
- Regemat 3D S.L.
- Regenovo Biotechnology Co. Ltd.
- Renishaw PLC.
- Revotek Co., Ltd.
- Rokit Healthcare, Inc.
- Stratasys Ltd.
- Vivax Bio, LLC